Boston An independent LDT provider
NOTE:Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here: https://rb.gy/09bxx

Listing (2015)

Prospectus for Immunovia AB, prior to listing on Nasdaq First North.

Prospekt Nasdaq First North 2015 (PDF in Swedish)

Link to Immunovia’s Financial Reports.